Answers are grounded in this paper and cite their sources.
Background Neuroendocrine tumors frequently metastasize to the liver. The size and number of neuroendocrine liver metastases (NELM) are prognostic. Studies have often dichotomized these variables, limiting nuanced risk assessment. We aimed to determine whether continuous-variable prognostic models stratified by primary tumor site refine survival prediction after hepatic cytoreduction. Methods We analyzed 329 patients who underwent hepatic cytoreduction for NELM at three international centers during 1995–2024. NELM characteristics, including largest diameter and number of metastases, were modeled as continuous variables. Overall survival (OS) and recurrence-free survival (RFS) were estimated using Kaplan–Meier analysis. Prognostic contour plots of 10-year OS estimates as a function of largest NELM diameter, plotted on the x-axis, and NELM number, plotted on the y-axis, were generated separately for small intestinal neuroendocrine tumors (SINET) and pancreatic neuroendocrine tumors (PNET). Results Median follow-up was 11.0 years (95% confidence interval 10.4–15.6). The 10-year OS rate was 71.0% for SINET and 44.4% for PNET ( p < 0.001). The 10-year RFS rate was 18.2% for SINET and 4.9% for PNET ( p < 0.001). The SINET contour plot had vertical contour lines, indicating that largest tumor diameter was the predominant prognostic factor, whereas the PNET contour plot had diagonal contour lines, indicating that both diameter and number contributed substantially. Conclusions The prognostic impacts of NELM largest diameter and number differ by tumor origin, with largest diameter predominating in SINET and both diameter and number being important in PNET. Clinicians should not exclude patients from SINET resection solely because of high tumor number.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: